Thirty patients with genetically proven LGMDR2 and 45 with IMNM (15 with the anti-SRP autoantibody, 15 with the anti-HMGCR autoantibody, and 15 with seronegative IMNM) were selected from one hundred patients who underwent muscle MRI examinations for myopathy between July 2014 and August 2022. Here, UCN2 is linked to myopathy.